These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 15238641)
21. SAPHO syndrome in an adult with ulcerative colitis responsive to intravenous pamidronate: a case report and review of the literature. Siau K; Laversuch CJ Rheumatol Int; 2010 Jun; 30(8):1085-8. PubMed ID: 19551383 [TBL] [Abstract][Full Text] [Related]
22. In SAPHO syndrome anti-TNF-alpha therapy may induce persistent amelioration of osteoarticular complaints, but may exacerbate cutaneous manifestations. Massara A; Cavazzini PL; Trotta F Rheumatology (Oxford); 2006 Jun; 45(6):730-3. PubMed ID: 16403830 [TBL] [Abstract][Full Text] [Related]
23. Effect of intravenous pamidronate therapy on everyday activities in children with osteogenesis imperfecta. Löwing K; Aström E; Oscarsson KA; Söderhäll S; Eliasson AC Acta Paediatr; 2007 Aug; 96(8):1180-3. PubMed ID: 17578486 [TBL] [Abstract][Full Text] [Related]
24. Treatment of SAPHO with pamidronate. Courtney PA; Hosking DJ; Fairbairn KJ; Deighton CM Rheumatology (Oxford); 2002 Oct; 41(10):1196-8. PubMed ID: 12364646 [No Abstract] [Full Text] [Related]
25. Successful treatment of primary chronic osteomyelitis in SAPHO syndrome with bisphosphonates. Just A; Adams S; Brinkmeier T; Barsegian V; Lorenzen J; Schilling F; Frosch P J Dtsch Dermatol Ges; 2008 Aug; 6(8):657-60. PubMed ID: 18266863 [TBL] [Abstract][Full Text] [Related]
26. Long-delayed onset of chest wall pain defining a patient with SAPHO syndrome. Touma Z; Arayssi T J Clin Rheumatol; 2007 Dec; 13(6):338-40. PubMed ID: 18176144 [TBL] [Abstract][Full Text] [Related]
27. SAPHO syndrome presenting as septic arthritis in the hip. O'Connor DA; Ridha H; Roche CJ; O'Sullivan M Ir Med J; 2003 Feb; 96(2):41-2. PubMed ID: 12674151 [TBL] [Abstract][Full Text] [Related]
29. Pamidronate does not adversely affect bone intrinsic material properties in children with osteogenesis imperfecta. Weber M; Roschger P; Fratzl-Zelman N; Schöberl T; Rauch F; Glorieux FH; Fratzl P; Klaushofer K Bone; 2006 Sep; 39(3):616-22. PubMed ID: 16644299 [TBL] [Abstract][Full Text] [Related]
30. Joint hypermobility syndrome in childhood. A not so benign multisystem disorder? Adib N; Davies K; Grahame R; Woo P; Murray KJ Rheumatology (Oxford); 2005 Jun; 44(6):744-50. PubMed ID: 15728418 [TBL] [Abstract][Full Text] [Related]
31. SAPHO syndrome treatment with intravenous pamidronate. Retrospective study of 22 patients. Delattre E; Guillot X; Godfrin-Valnet M; Prati C; Wendling D Joint Bone Spine; 2014 Oct; 81(5):456-8. PubMed ID: 24561020 [No Abstract] [Full Text] [Related]
32. Disease burden, disease manifestations and current treatment regimen of the SAPHO syndrome in Germany: results from a nationwide patient survey. Witt M; Meier J; Hammitzsch A; Proft F; Schulze-Koops H; Grunke M Semin Arthritis Rheum; 2014 Jun; 43(6):745-50. PubMed ID: 24816195 [TBL] [Abstract][Full Text] [Related]
33. [Methotrexate to treat SAPHO syndrome with keloidal scars]. Azevedo VF; Dal Pizzol VI; Lopes H; Coelho SP; Czeczko LE Acta Reumatol Port; 2011; 36(2):167-70. PubMed ID: 21841736 [TBL] [Abstract][Full Text] [Related]
34. Nd:YAG laser biostimulation in the treatment of bisphosphonate-associated osteonecrosis of the jaw: clinical experience in 28 cases. Vescovi P; Merigo E; Manfredi M; Meleti M; Fornaini C; Bonanini M; Rocca JP; Nammour S Photomed Laser Surg; 2008 Feb; 26(1):37-46. PubMed ID: 18248160 [TBL] [Abstract][Full Text] [Related]